Dr. Caroline A. MacCallum

MD, FRCPC (Internal Medicine), BSc Pharm

  • Department of Medicine, Faculty of Medicine, Division of Community Internal Medicine, University of British Columbia (UBC)
  • Department of Medicine, Faculty of Medicine, Division of Palliative Care, UBC
  • Faculty of Pharmaceutical Sciences, UBC
  • Greenleaf Medical Clinic

Dr. Caroline MacCallum is a specialist in internal medicine, with expertise in complex pain and cannabinoid medicine. She is a clinical instructor in the Department of Medicine; Adjunct Professor in the Faculty of Pharmaceutical Sciences program; and associate member in the Dept. of Palliative Care at the University of British Columbia.

Dr. MacCallum is the medical director of Greenleaf Medical Clinic, where she has assessed and developed cannabinoid treatment plans for more than 5,000 patients using legal medical cannabis approved by Health Canada.

Caroline MacCallum is the primary author of Practical Considerations for Medical Cannabis Administration and Dosing, published in the European Journal of Internal Medicine, which has been cited over 250 times. She is the assistant editor for the Cannabinoids and Pain book by Springer; and first author on eight chapters pertaining to pharmacovigilance including: mental health, impairment, dosing, patient safety (contraindications & drug interactions), use in adolescence, product safety, pain, and opioid substitution.

Dr. MacCallum has presented internationally on the topic of cannabis dosing, safety and polypharmacy reduction/substitution. She has qualified as a medical cannabis expert and testified in arbitration for a claim involving a challenge to Health Canada’s 24-hour rule for cannabis impairment. Dr. MacCallum is currently working with university research groups, hospitals, health benefit programs, provincial and national committees to create; guidelines, safe prescribing practices, clinical trials, patient registries and adverse event monitoring.

Her research interests focus on the use of cannabis as an adjuvant to standard of care for complex conditions including: chronic pain, fibromyalgia/chronic fatigue syndrome, neurodevelopmental disorders, post-traumatic stress disorder, and traumatic brain injury; deprescribing/drug substitution; pharmacovigilance and impairment.

UBC Pain Research Network Profile

Vancouver Coastal Health Research Institute Profile

Frontiers (Loop) Science Research Network Profile


Rapid response to ‘Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline’. BMJ. 2021 – https://doi.org/10.1136/bmj.n2040

Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research. 2021 – https://doi.org/10.1186/s42238-021-00073-1

Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine. 2021 – https://doi.org/10.1016/j.ejim.2021.05.002

Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Frontiers in Pharmacology. 2021 – https://doi.org/10.3389/fphar.2021.633168

Duration of neurocognitive impairment with medical cannabis use: a scoping review. Frontiers in Psychiatry. 2021 – https://doi.org/10.3389/fpsyt.2021.638962

Guidance in Authorizing Cannabis Products Within Primary Care © 2021 The College of Family Physicians of Canada

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. BMJ Open. 2020;10:e036114 – http://dx.doi.org/10.1136/bmjopen-2019-036114

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. BMC Psychiatry. 2019;19:335 – https://doi.org/10.1186/s12888-019-2324-z

Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018;49 – https://doi.org/10.1016/j.ejim.2018.01.004



This site is dedicated to those patients (and their families and care providers) who have lived with chronic conditions, found improvement in symptoms, function and quality of life with medical cannabis.

My dream is that one day cannabis will be legalized worldwide; stigma and barriers to access will be no more, and patients can experience a better quality of life.

Huge appreciation to my cannabis team who have supported me over the years and without them none of this would be possible:

  • Lindsay Lo
  • Michael Boivin
  • Dr. Ethan Russo
  • Dr. Dustin Sulak
  • Dr. Bonni Goldstein
  • Dr. Zach Walsh
  • Dr. Maria Fernanda Arboleda
  • Dr. Danial Schecter
  • Jag Deol
  • Fonda Betts
  • Tanya Adams
  • Dr. Lauren Eadie
  • Dr. Chris Spooner
  • Dr. Jenna Valleriani
  • Dr. Shaohua Lu
  • Dr. Dana Lambert
  • Nishi Whiteley
  • Carly Pistawka
  • April Christiansen
  • Michael Koehn
  • Dr. Alasdair Barr
  • Dr. William Panenka
  • Greenleaf Medical Clinic
  • Andrew Cuscianna